Undifferentiated Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of Neoadjuvant Checkpoint Blockade in Patients With Surgically Resectable Undifferentiated Pleomorphic Sarcoma and Dedifferentiated Liposarcoma
Condition: Systemic Connective Tissue Disorders Interventions: Drug: Nivolumab; Drug: Ipilimumab; Radiation: Radiation Therapy Sponsors: M.D. Anderson Cancer Center; Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2017 Category: Research Source Type: clinical trials

Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
Condition: Thyroid Gland Undifferentiated (Anaplastic) Carcinoma Interventions: Drug: Docetaxel; Drug: Doxorubicin Hydrochloride; Radiation: Intensity-Modulated Radiation Therapy; Other: Laboratory Biomarker Analysis; Biological: Pembrolizumab; Procedure: Therapeutic Conventional Surgery Sponsors: Mayo Clinic; National Cancer Institute (NCI) Not yet recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2017 Category: Research Source Type: clinical trials